Application: 4-Iodo-1-chloro-2-(4-ethoxybenzyl)benzene (CAS #1103738-29-9 ) can be used as a reagent in the synthesis of Dapagliflozin (D185370); a potent, selective renal sodium-dependent glucose cotransporter 2 (SGLT2) inhibitor for the treatment of type 2 diabetes.

Huateng Pharma can provide dapagliflozin intermediates (CAS# 1103738-29-9) from lab to commercial scale. We can also provide CDMO services with sufficient capacity. Contact us at sales@huatengusa.com now.

Find More Dapagliflozin Intermediates >>